Entacapone provides benefit to Parkinson's disease patients with motor fluctuations treated with levodopa and dopamine agonists:: An analysis of four randomized trials

被引：0
|
作者：
Kuoppamäki, M
Vahteristo, M
Kieburtz, K
机构：
来源：
MOVEMENT DISORDERS | 2005年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P467
引用
收藏
页码：S137 / S138
页数：2
相关论文
共 50 条
  • [21] A randomized, double-blind study to compare the effect on quality of life of levodopa/carbidopa/entacapone (Stalevo®) with levodopa/carbidopa in patients with Parkinson's disease with no or minimal, nondisabling motor fluctuations
    Fung, V. S.
    MOVEMENT DISORDERS, 2006, 21 : S446 - S446
  • [22] Impact of 3-month earlier versus later initiation of opicapone versus entacapone in levodopa-treated patients with Parkinson's disease and motor fluctuations
    Carroll, Camille
    Lees, Andrew
    Ferreira, Joaquim
    Fonseca, Miguel
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 280 - 281
  • [23] Effect of opicapone and entacapone on daily pattern of motor fluctuations in Parkinson's disease patients
    Lees, A.
    Rascol, O.
    Ferreira, J.
    Klepitskaya, O.
    Fonseca, M.
    Magalhaes, D.
    Rocha, J. -F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2020, 35 : S461 - S461
  • [24] Tolerability and Safety of Ropinirole versus Other Dopamine Agonists and Levodopa in the Treatment of Parkinson's Disease Meta-Analysis of Randomized Controlled Trials
    Kulisevsky, Jaime
    Pagonabarraga, Javier
    DRUG SAFETY, 2010, 33 (02) : 147 - 161
  • [25] Adherence with levodopa/carbidopa/entacapone versus levodopa/carbidopa and entacapone as separate tablets in patients with Parkinson's disease
    Delea, Thomas E.
    Thomas, Simu K.
    Hagiwara, May
    Mancione, L.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (07) : 1543 - 1552
  • [26] Levodopa/DDCI and entacapone is the preferred treatment for Parkinson's disease patients with motor fluctuations in routine practice: A retrospective, observational analysis of a large French cohort
    Damier, P.
    Viallet, F.
    Ziegler, M.
    Bourdeix, I.
    Rerat, K.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (07) : 643 - 648
  • [27] Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations
    Borgohain, Rupam
    Szasz, J.
    Stanzione, P.
    Meshram, C.
    Bhatt, M.
    Chirilineau, D.
    Stocchi, F.
    Lucini, V.
    Giuliani, R.
    Forrest, E.
    Rice, P.
    Anand, R.
    MOVEMENT DISORDERS, 2014, 29 (02) : 229 - 237
  • [28] Efficacy and safety of safinamide as a levodopa adjunct in patients with parkinson disease and motor fluctuations: A systematic review of randomized controlled trials
    Hussain, S.
    Najmi, A.
    MOVEMENT DISORDERS, 2018, 33 : S101 - S101
  • [29] A comparative randomised study of rasagiline versus placebo or entacapone as adjunct to levodopa in Parkinson's disease patients with motor fluctuations (the LARGO Study)
    Rascol, O
    MOVEMENT DISORDERS, 2004, 19 : S200 - S201
  • [30] Rasagiline as add on therapy in levodopa-treated patients with Parkinson's disease and motor fluctuations: A randomized placebo-controlled study
    Oztekin, N.
    Oztekin, F.
    Okkan, H.
    Ak, F.
    Bilen, S.
    MOVEMENT DISORDERS, 2009, 24 : S271 - S272
12345